Skip to content
Scottsdale Joint Care
A field guide to status, evidence and fit

Scottsdale Joint Care

Questions to ask when a joint stays sore

A nagging ache can make you wonder whether to rest, call, or ask about a procedure. The answers below take those choices one at a time.

Joint regeneration is a label for clinic care using your blood or material from another body tissue. It doesn't promise that worn parts of a joint will grow back.

Why is my joint stiff when I first get up?

Hours with little movement can leave a joint stiff. Arthritis, an old injury, swelling, or a sore tendon may add to it. A tendon is a strong band that joins muscle to bone. Easy motion may help, but note how long the stiffness lasts and whether it worsens.

What can I try at home for the ache?

Ease back from the chore or sport that starts the ache, then move within comfort. Warmth may loosen stiffness, while brief cooling can calm swelling after activity. Try a few easy periods of movement rather than one hard effort. Ask your doctor about safe medicine, especially when other drugs are part of your day.

When does joint soreness need an exam?

Call for an exam when soreness often comes back, disturbs sleep, or limits walking. Repeated swelling, locking, weakness, and lost motion deserve earlier care. Seek quick help when fever comes with marked heat and swelling. A clear change in joint shape or sudden loss of support also needs prompt care.

What does PRP stand for, and what happens during the procedure?

The letters PRP stand for platelet-rich plasma. A clinician takes a blood sample, spins it to collect platelets, then puts the prepared portion into the sore joint. Concentrated PRP follows those steps but collects a higher share of platelets. Ask why that form fits your exam, because people don't all respond alike.

What does QC Kinetix offer when the soreness continues?

QC Kinetix can discuss non-surgical regenerative treatments prepared from blood or another kind of body tissue. An exam comes before any clinic procedure. Medical providers are trained clinicians who examine the joint and perform the procedure. Ask which material will be used, where it will be placed, and what relief remains uncertain.

Will insurance pay for a regenerative procedure?

Your health plan and the service itself decide whether there is coverage. Many regenerative procedures are paid for directly instead of through routine coverage. Ask the clinic to give you the full price and any later costs before calling your insurer. Medicare has its own rules, so don't assume one answer fits every plan.

Sources

  1. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

    US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.

  2. Medicare's National Coverage Determination covers autologous platelet-rich plasma ONLY for chronic non-healing diabetic, pressure or venous WOUNDS, and only under Coverage with Evidence Development inside an approved clinical research study. There is no Medicare coverage pathway for PRP as a treatment for osteoarthritis or any other joint indication, which is why these injections are quoted as cash prices.

    Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2012.

  3. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

    Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

  4. FDA's guidance on the 21 CFR 1271.10(a) criteria of MINIMAL MANIPULATION and HOMOLOGOUS USE is the rule that decides whether a cell or tissue product may be offered as a lightly-regulated 'section 361' HCT/P or requires full drug approval as a 'section 351' biologic. Docket FDA-2017-D-6146; the revised July 2020 version extended the agency's period of enforcement discretion through 31 May 2021 - which has now expired, so products outside 361 need an approved application or an active IND.

    US Food and Drug Administration, CBER and CDRH — Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. FDA, 2020.

  5. MACI (autologous cultured chondrocytes on a porcine collagen membrane, Vericel; STN BL 125603) IS an FDA-LICENSED cell therapy - and its approved indication is narrow and specific: repair of symptomatic, single or multiple FULL-THICKNESS cartilage defects OF THE KNEE, with or without bone involvement, in adults. It is not approved for osteoarthritis. The existence of one licensed cartilage cell therapy for focal defects is the sharpest available way to show what a licensed 'regeneration' product actually looks like, and how far it is from an injection for a worn joint.

    US Food and Drug Administration, Center for Biologics Evaluation and Research — MACI (autologous cultured chondrocytes on porcine collagen membrane). FDA, 2024.

  6. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit.

    Awad G, et al. — Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.. Clinical rheumatology, 2026. DOI: 10.1007/s10067-026-08042-w.

What to do when soreness does not settle

At its Scottsdale clinic, QC Kinetix offers regenerative treatments made with blood or another tissue from the body. These non-surgical procedures follow an exam and a consultation.

Take a medicine list, earlier images, and a short note about the activity that hurts. Call (602) 837-PAIN when you're ready to arrange the visit.

Talk to the clinic team